A repurposed drug could open door to more stem cell transplants
Credit: UBC/Paul Joseph A medication used to treat joint and skin conditions might also help people whose only hope of surviving cancer is receiving stem...
NEWS INDEX
After the diagnosis: How cancer affects sexual functioning
Credit: University of Houston A cancer diagnosis disrupts a person's life in many ways, including sexually. A study led by the University of Houston found...
Electron microscope images reveal how cells absorb a vital mineral
Credit: Credit: Sobolevsky lab/CUMC New York, NY (Dec. 20, 2017) -- Columbia University Medical Center (CUMC) researchers have obtained the first detailed snapshots of the...
Molecular super enhancers: A new key for targeted therapy of brain cancer in children
Ependymoma refers to a heterogeneous group of cancers that can occur at any age and is one of the most common types of brain cancer...
Low-dose X-ray exposure does not harm human stem cells
Credit: MIPT Press Office Biophysicists have shown that following low-dose exposure to X-rays (at 80 milligrays), stem cells remain healthy, proliferate, and do not accumulate...
Smartphone app monitors cancer patients recovery
PITTSBURGH, Dec. 20, 2017 - Cancer patients receiving chemotherapy can be remotely monitored using their smartphone sensors and an algorithm that detects worsening symptoms based...
Expensive new cancer therapy may be cost effective
AURORA, Colo. (Dec. 20, 2017) - Researchers from the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, selected to estimate the cost-effectiveness of...
Many brain tumor patients do not receive adequate end-of-life care
While more than 60 percent of patients with the brain tumors called malignant gliomas enroll in hospice services, almost a quarter of them do so...
Harnessing sperm to treat gynecological diseases
Credit: American Chemical Society Delivering drugs specifically to cancer cells is one approach researchers are taking to minimize treatment side effects. Stem cells, bacteria and...
Results from Alliance CABOSUN trial lead to US FDA approval of extended indication
The Alliance for Clinical Trials in Oncology (the Alliance), in conjunction with industry partner Exelixis, today announced that the U.S. Food and Drug Administration (FDA)...
Overlooked immune cells hold breakthrough for treating aggressive cancers
Credit: Medical University of South Carolina The latest generation of cancer treatments spring from the discovery that the human immune system is able to beat...
NIH study uncovers clues about why common cancer drug causes hearing loss
Scientists have found a new way to explain the hearing loss caused by cisplatin, a powerful drug used to treat many forms of cancer. Using...
Ludwig researchers uncover mechanism behind metabolic vulnerability of some breast cancers
Credit: Ludwig Cancer Research DECEMBER 19, 2017, New York -- Scientists have known since the 1980s that many cancer cells are relatively sensitive to the...
DNA annotations predict patient outcomes in childhood leukemia
UC San Francisco physician-scientists have developed a test that can predict how patients with juvenile myelomonocytic leukemia (JMML) will respond to treatment, and may also...
Novel combination therapy shown to be effective in ovarian cancer
PHILADELPHIA -- (Dec. 19, 2017) -- Researchers at The Wistar Institute have found that combining PARP inhibitors, recently approved for the treatment of BRCA-mutant ovarian...
